Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 1999, p. 3278-3288, Vol. 19, No. 5
Istituto di Medicina Interna,
Received 22 September 1998/Returned for modification 25 October
1998/Accepted 25 January 1999
Insulin-like growth factor II (IGF-II) is a peptide growth factor
that is homologous to both insulin-like growth factor I (IGF-I) and
insulin and plays an important role in embryonic development and
carcinogenesis. IGF-II is believed to mediate its cellular signaling
via the transmembrane tyrosine kinase type 1 insulin-like growth factor
receptor (IGF-I-R), which is also the receptor for IGF-I. Earlier
studies with both cultured cells and transgenic mice, however, have
suggested that in the embryo the insulin receptor (IR) may also be a
receptor for IGF-II. In most cells and tissues, IR binds IGF-II with
relatively low affinity. The IR is expressed in two isoforms (IR-A and
IR-B) differing by 12 amino acids due to the alternative splicing of
exon 11. In the present study we found that IR-A but not IR-B bound
IGF-II with an affinity close to that of insulin. Moreover, IGF-II
bound to IR-A with an affinity equal to that of IGF-II binding to the
IGF-I-R. Activation of IR-A by insulin led primarily to metabolic
effects, whereas activation of IR-A by IGF-II led primarily to
mitogenic effects. These differences in the biological effects of IR-A
when activated by either IGF-II or insulin were associated with
differential recruitment and activation of intracellular substrates.
IR-A was preferentially expressed in fetal cells such as fetal
fibroblasts, muscle, liver and kidney and had a relatively increased
proportion of isoform A. IR-A expression was also increased in several
tumors including those of the breast and colon. These data indicate,
therefore, that there are two receptors for IGF-II, both IGF-I-R and
IR-A. Further, they suggest that interaction of IGF-II with IR-A may
play a role both in fetal growth and cancer biology.
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Insulin Receptor Isoform A, a Newly Recognized,
High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and
Cancer Cells
*
Corresponding author. Mailing address: Cattedra di
Endocrinologia, Ospedale Garibaldi, 95123 Catania, Italy. Phone:
39-095-32 62 90. Fax: 39-095-715 80 72. E-mail:
segmeint{at}mbox.unict.it.
Molecular and Cellular Biology, May 1999, p. 3278-3288, Vol. 19, No. 5
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|